Debanjana Chatterjee
Stock Analyst at Jones Trading
(3.51)
# 838
Out of 5,173 analysts
16
Total ratings
69.23%
Success rate
16.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics | Maintains: Buy | $25 → $24 | $10.76 | +123.05% | 1 | Mar 19, 2026 | |
| NTLA Intellia Therapeutics | Upgrades: Buy | $29 | $13.11 | +121.21% | 3 | Mar 4, 2026 | |
| ARMP Armata Pharmaceuticals | Initiates: Buy | $15 | $8.09 | +85.41% | 1 | Jan 5, 2026 | |
| SYRE Spyre Therapeutics | Upgrades: Buy | $64 | $42.76 | +49.67% | 2 | Dec 1, 2025 | |
| SION Sionna Therapeutics | Initiates: Buy | $46 | $36.43 | +26.27% | 1 | Sep 8, 2025 | |
| TBPH Theravance Biopharma | Initiates: Buy | $24 | $14.75 | +62.71% | 1 | Jun 17, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Buy | $15 → $27 | $4.88 | +453.28% | 2 | Jun 6, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Buy | $39 | $3.60 | +983.33% | 1 | Apr 28, 2025 | |
| KALV KalVista Pharmaceuticals | Maintains: Buy | $30 | $16.60 | +80.72% | 2 | Mar 26, 2025 | |
| CTNM Contineum Therapeutics | Initiates: Buy | $23 | $12.42 | +85.19% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $46 | $25.70 | +78.99% | 1 | Sep 19, 2024 |
Trevi Therapeutics
Mar 19, 2026
Maintains: Buy
Price Target: $25 → $24
Current: $10.76
Upside: +123.05%
Intellia Therapeutics
Mar 4, 2026
Upgrades: Buy
Price Target: $29
Current: $13.11
Upside: +121.21%
Armata Pharmaceuticals
Jan 5, 2026
Initiates: Buy
Price Target: $15
Current: $8.09
Upside: +85.41%
Spyre Therapeutics
Dec 1, 2025
Upgrades: Buy
Price Target: $64
Current: $42.76
Upside: +49.67%
Sionna Therapeutics
Sep 8, 2025
Initiates: Buy
Price Target: $46
Current: $36.43
Upside: +26.27%
Theravance Biopharma
Jun 17, 2025
Initiates: Buy
Price Target: $24
Current: $14.75
Upside: +62.71%
Sagimet Biosciences
Jun 6, 2025
Maintains: Buy
Price Target: $15 → $27
Current: $4.88
Upside: +453.28%
Tvardi Therapeutics
Apr 28, 2025
Initiates: Buy
Price Target: $39
Current: $3.60
Upside: +983.33%
KalVista Pharmaceuticals
Mar 26, 2025
Maintains: Buy
Price Target: $30
Current: $16.60
Upside: +80.72%
Contineum Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $23
Current: $12.42
Upside: +85.19%
Sep 19, 2024
Initiates: Buy
Price Target: $46
Current: $25.70
Upside: +78.99%